Tag: Biotech and Pharma

Johnson & Johnson  agreed to acquire medical-devices maker Shockwave Medical  for a total enterprise value of about $13.1 billion.

Moderna announced positive clinical trial data on three experimental vaccines and said it will move those shots to final stage studies.

The FDA approved a drug from Merck designed to treat a rare, progressive and life-threatening lung condition called pulmonary arterial hypertension.

Eli Lilly said Amazon Pharmacy will help deliver certain prescription drugs, including the popular weight loss treatment Zepbound, directly to patients’ homes through the drugmaker’s new direct-to-consumer website. 

The company told an investor meeting that the Phase I trial of its highly-anticipated obesity drug amycretin showed a 13.1% weight loss in participants after 12 weeks, according to Reuters.

Η LavipharmΛΑΒΙ -0,64% A.E. ανακοίνωσε ότι οι ενοποιημένες Πωλήσεις από συνεχιζόμενη δραστηριότητα προ Rebate & Clawback ανήλθαν σε Ευρώ 57,43 εκατ. το 2023 έναντι Ευρώ 45,14 εκατ. κατά τη χρήση 2022, παρουσιάζοντας αύξηση κατά 27,2%.

Vaccine maker Novavax on Wednesday reported fourth-quarter revenue and earnings that missed Wall Street’s estimates and reiterated plans to cut costs as it fights to stay afloat. 

Patients saw “significant” reductions in body weight during a study of a weight-loss drug developed by Viking Therapeutics sending shares of the biopharmaceutical company soaring in premarket trading Tuesday.

Shares of Denmark’s Zealand Pharma shot 32% higher in morning trade, after results showed success in its liver disease treatment survodutide, which is also on trial as a drug to treat obesity.

Moderna posted a surprise quarterly profit, in part boosted by deferred revenue, even as the company saw slumping sales from its Covid vaccine, its only marketable product. 

Ιστορική μέρα η σημερινή για την Lavipharm, καθώς 1,5 χρόνο μετά την αύξηση κεφαλαίου που άλλαξε τον ρου της εισηγμένης στη χρηματιστηριακή θάλασσα, γίνεται πράξη η είσοδό της στην φαρμακευτική κάνναβη και όλα δείχνουν πως πραγματώνεται ο στόχος για εκτίναξη των EBITDA ως το 2025.

Τη διακοπή της δραστηριότητας φαρμακαποθήκης και υπηρεσιών logistics προς τρίτους ανακοίνωσε η Lavipharm, καθώς και τη μεταβίβαση ορισμένων στοιχείων του ενεργητικού της θυγατρικής της εταιρείας LAS στην Profarm.

Kenvue Inc.’s stock fell 2.6% early Thursday, after the consumer-health business spun out from Johnson & Johnson last year missed revenue estimates for the fourth quarter and offered soft guidance for 2024.

AstraZeneca sees its revenue and core earnings per share growing by double-digit percentages in 2024, the pharmaceuticals major said as it reported fourth-quarter core earnings per share below expectations on higher costs, sending the stock lower.

Eli Lilly reported fourth-quarter revenue and adjusted earnings that topped expectations on the strong launch of its new weight loss drug, Zepbound, and higher prices for its blockbuster diabetes treatment, Mounjaro.

Novo Holdings, parent of Novo Nordisk (NOVOb.CO), opens new tab, will buy contract drugmaker Catalent (CTLT.N), opens new tab for $11.5 billion in cash to help meet the strong demand for its popular weight-loss drug Wegovy, the companies said on Monday.

Merck reported fourth-quarter revenue and adjusted earnings that topped estimates as it saw strong demand for its blockbuster cancer drug Keytruda and HPV vaccine Gardasil.

The maker of weight loss drug Wegovy and diabetes drug Ozempic reported an increase in sales of 31% in Danish kroner and 36% at constant exchange rates to 232.3 billion kroner ($33.71 billion).

Pfizer posted a surprise adjusted fourth-quarter profit, as the company’s declining Covid business performed better than expected.

Shares in Bayer dropped as much as 5.7% on Monday after the embattled German company was ordered to pay $2.25 billion in damages, the highest amount yet in its ongoing litigation linked to an alleged carcinogenic effect of its Roundup weedkiller.